Rabaca, Saharish P.

HRN: 29-23-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/03/2026
07/10/2026
IV
39mg
Q24H
T/c Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: